Table of Contents Executive Summary 1 Industry Overview of PEGylated Drugs 1.1 Definition of PEGylated Drugs 1.2 PEGylated Drugs Segment by Type 1.2.1 Global PEGylated Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Linkers 1.2.3 Cross-Linkers 1.2.4 Other 1.3 PEGylated Drugs Segment by Applications 1.3.1 Global PEGylated Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Cancer 1.3.3 Chronic Kidney Diseases 1.3.4 Hepatitis 1.3.5 Multiple Sclerosis 1.3.6 Hemophilia 1.3.7 Gastrointestinal Disorders 1.4 Global PEGylated Drugs Overall Market 1.4.1 Global PEGylated Drugs Revenue (2014-2025) 1.4.2 Global PEGylated Drugs Production (2014-2025) 1.4.3 North America PEGylated Drugs Status and Prospect (2014-2025) 1.4.4 Europe PEGylated Drugs Status and Prospect (2014-2025) 1.4.5 China PEGylated Drugs Status and Prospect (2014-2025) 1.4.6 Japan PEGylated Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia PEGylated Drugs Status and Prospect (2014-2025) 1.4.8 India PEGylated Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of PEGylated Drugs 2.3 Manufacturing Process Analysis of PEGylated Drugs 2.4 Industry Chain Structure of PEGylated Drugs 3 Development and Manufacturing Plants Analysis of PEGylated Drugs 3.1 Capacity and Commercial Production Date 3.2 Global PEGylated Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of PEGylated Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 PEGylated Drugs Production and Capacity Analysis 4.2 PEGylated Drugs Revenue Analysis 4.3 PEGylated Drugs Price Analysis 4.4 Market Concentration Degree 5 PEGylated Drugs Regional Market Analysis 5.1 PEGylated Drugs Production by Regions 5.1.1 Global PEGylated Drugs Production by Regions 5.1.2 Global PEGylated Drugs Revenue by Regions 5.2 PEGylated Drugs Consumption by Regions 5.3 North America PEGylated Drugs Market Analysis 5.3.1 North America PEGylated Drugs Production 5.3.2 North America PEGylated Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America PEGylated Drugs Import and Export 5.4 Europe PEGylated Drugs Market Analysis 5.4.1 Europe PEGylated Drugs Production 5.4.2 Europe PEGylated Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe PEGylated Drugs Import and Export 5.5 China PEGylated Drugs Market Analysis 5.5.1 China PEGylated Drugs Production 5.5.2 China PEGylated Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China PEGylated Drugs Import and Export 5.6 Japan PEGylated Drugs Market Analysis 5.6.1 Japan PEGylated Drugs Production 5.6.2 Japan PEGylated Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan PEGylated Drugs Import and Export 5.7 Southeast Asia PEGylated Drugs Market Analysis 5.7.1 Southeast Asia PEGylated Drugs Production 5.7.2 Southeast Asia PEGylated Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia PEGylated Drugs Import and Export 5.8 India PEGylated Drugs Market Analysis 5.8.1 India PEGylated Drugs Production 5.8.2 India PEGylated Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India PEGylated Drugs Import and Export 6 PEGylated Drugs Segment Market Analysis (by Type) 6.1 Global PEGylated Drugs Production by Type 6.2 Global PEGylated Drugs Revenue by Type 6.3 PEGylated Drugs Price by Type 7 PEGylated Drugs Segment Market Analysis (by Application) 7.1 Global PEGylated Drugs Consumption by Application 7.2 Global PEGylated Drugs Consumption Market Share by Application (2014-2019) 8 PEGylated Drugs Major Manufacturers Analysis 8.1 Thermo Fisher Scientific 8.1.1 Thermo Fisher Scientific PEGylated Drugs Production Sites and Area Served 8.1.2 Thermo Fisher Scientific Product Introduction, Application and Specification 8.1.3 Thermo Fisher Scientific PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Merck 8.2.1 Merck PEGylated Drugs Production Sites and Area Served 8.2.2 Merck Product Introduction, Application and Specification 8.2.3 Merck PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Johnson & Johnson 8.3.1 Johnson & Johnson PEGylated Drugs Production Sites and Area Served 8.3.2 Johnson & Johnson Product Introduction, Application and Specification 8.3.3 Johnson & Johnson PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Creative PEGworks 8.4.1 Creative PEGworks PEGylated Drugs Production Sites and Area Served 8.4.2 Creative PEGworks Product Introduction, Application and Specification 8.4.3 Creative PEGworks PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 NOF 8.5.1 NOF PEGylated Drugs Production Sites and Area Served 8.5.2 NOF Product Introduction, Application and Specification 8.5.3 NOF PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Quanta BioDesign Celares Biomatrik 8.6.1 Quanta BioDesign Celares Biomatrik PEGylated Drugs Production Sites and Area Served 8.6.2 Quanta BioDesign Celares Biomatrik Product Introduction, Application and Specification 8.6.3 Quanta BioDesign Celares Biomatrik PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Iris Biotech Laysan Bio 8.7.1 Iris Biotech Laysan Bio PEGylated Drugs Production Sites and Area Served 8.7.2 Iris Biotech Laysan Bio Product Introduction, Application and Specification 8.7.3 Iris Biotech Laysan Bio PEGylated Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of PEGylated Drugs Market 9.1 Global PEGylated Drugs Market Trend Analysis 9.1.1 Global PEGylated Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 PEGylated Drugs Regional Market Trend 9.2.1 North America PEGylated Drugs Forecast 2019-2025 9.2.2 Europe PEGylated Drugs Forecast 2019-2025 9.2.3 China PEGylated Drugs Forecast 2019-2025 9.2.4 Japan PEGylated Drugs Forecast 2019-2025 9.2.5 Southeast Asia PEGylated Drugs Forecast 2019-2025 9.2.6 India PEGylated Drugs Forecast 2019-2025 9.3 PEGylated Drugs Market Trend (Product Type) 9.4 PEGylated Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 PEGylated Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of PEGylated Drugs Table Global PEGylated Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global PEGylated Drugs Production Market Share by Types in 2018 Figure Linkers Product Picture Figure Cross-Linkers Product Picture Figure Other Product Picture Table Global PEGylated Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global PEGylated Drugs Consumption Market Share by Applications in 2018 Figure Cancer Figure Chronic Kidney Diseases Figure Hepatitis Figure Multiple Sclerosis Figure Hemophilia Figure Gastrointestinal Disorders Figure Global PEGylated Drugs Revenue (Million USD) (2014-2025) Figure Global PEGylated Drugs Production (K Units) (2014-2025) Figure North America PEGylated Drugs Market Size (Million USD) (2014-2025) Figure Europe PEGylated Drugs Market Size (Million USD) (2014-2025) Figure China PEGylated Drugs Market Size (Million USD) (2014-2025) Figure Japan PEGylated Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia PEGylated Drugs Market Size (Million USD) (2014-2025) Figure India PEGylated Drugs Market Size (Million USD) (2014-2025) Table PEGylated Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of PEGylated Drugs in 2018 Figure Manufacturing Process Analysis of PEGylated Drugs Figure Industry Chain Structure of PEGylated Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global PEGylated Drugs Manufacturing Plants Distribution Table PEGylated Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table PEGylated Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table PEGylated Drugs Production (K Units) of Major Manufacturers (2014-2019) Table PEGylated Drugs Production Market Share of Major Manufacturers (2014-2019) Figure PEGylated Drugs Production Share by Manufacturers in 2018 Table PEGylated Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table PEGylated Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure PEGylated Drugs Revenue Share by Manufacturers in 2018 Table PEGylated Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global PEGylated Drugs Production by Regions 2014-2019 (K Units) Table Global PEGylated Drugs Production Market Share by Regions 2014-2019 Figure Global PEGylated Drugs Production Market Share by Regions in 2018 Table Global PEGylated Drugs Revenue by Regions 2014-2019 (Million USD) Table Global PEGylated Drugs Revenue Market Share by Regions 2014-2019 Figure Global PEGylated Drugs Revenue Market Share by Regions in 2018 Table Global PEGylated Drugs Consumption by Regions 2014-2019 (K Units) Table Global PEGylated Drugs Consumption Market Share by Regions 2014-2019 Figure North America PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure North America PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America PEGylated Drugs Production, Consumption Import and Export (K Units) Figure Europe PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe PEGylated Drugs Production, Consumption Import and Export (K Units) Figure China PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure China PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China PEGylated Drugs Production, Consumption Import and Export (K Units) Figure Japan PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan PEGylated Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia PEGylated Drugs Production, Consumption Import and Export (K Units) Figure India PEGylated Drugs Production Growth Rate 2014-2019 (K Units) Figure India PEGylated Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India PEGylated Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption PEGylated Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) PEGylated Drugs Market Share by Application (2014-2019) Table Thermo Fisher Scientific PEGylated Drugs Production Sites and Area Served Table Thermo Fisher Scientific PEGylated Drugs Product Introduction, Application and Specification Table Thermo Fisher Scientific PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Thermo Fisher Scientific PEGylated Drugs Production Growth Rate (2014-2019) Table Thermo Fisher Scientific PEGylated Drugs Production Market Share (2014-2019) Figure Thermo Fisher Scientific PEGylated Drugs Revenue Market Share (2014-2019) Table Thermo Fisher Scientific PEGylated Drugs Main Business and Markets Served Table Merck PEGylated Drugs Production Sites and Area Served Table Merck PEGylated Drugs Product Introduction, Application and Specification Table Merck PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck PEGylated Drugs Production Growth Rate (2014-2019) Table Merck PEGylated Drugs Production Market Share (2014-2019) Figure Merck PEGylated Drugs Revenue Market Share (2014-2019) Table Merck PEGylated Drugs Main Business and Markets Served Table Johnson & Johnson PEGylated Drugs Production Sites and Area Served Table Johnson & Johnson PEGylated Drugs Product Introduction, Application and Specification Table Johnson & Johnson PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson PEGylated Drugs Production Growth Rate (2014-2019) Table Johnson & Johnson PEGylated Drugs Production Market Share (2014-2019) Figure Johnson & Johnson PEGylated Drugs Revenue Market Share (2014-2019) Table Johnson & Johnson PEGylated Drugs Main Business and Markets Served Table Creative PEGworks PEGylated Drugs Production Sites and Area Served Table Creative PEGworks PEGylated Drugs Product Introduction, Application and Specification Table Creative PEGworks PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Creative PEGworks PEGylated Drugs Production Growth Rate (2014-2019) Table Creative PEGworks PEGylated Drugs Production Market Share (2014-2019) Figure Creative PEGworks PEGylated Drugs Revenue Market Share (2014-2019) Table Creative PEGworks PEGylated Drugs Main Business and Markets Served Table NOF PEGylated Drugs Production Sites and Area Served Table NOF PEGylated Drugs Product Introduction, Application and Specification Table NOF PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table NOF PEGylated Drugs Production Growth Rate (2014-2019) Table NOF PEGylated Drugs Production Market Share (2014-2019) Figure NOF PEGylated Drugs Revenue Market Share (2014-2019) Table NOF PEGylated Drugs Main Business and Markets Served Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Production Sites and Area Served Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Product Introduction, Application and Specification Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Production Growth Rate (2014-2019) Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Production Market Share (2014-2019) Figure Quanta BioDesign Celares Biomatrik PEGylated Drugs Revenue Market Share (2014-2019) Table Quanta BioDesign Celares Biomatrik PEGylated Drugs Main Business and Markets Served Table Iris Biotech Laysan Bio PEGylated Drugs Production Sites and Area Served Table Iris Biotech Laysan Bio PEGylated Drugs Product Introduction, Application and Specification Table Iris Biotech Laysan Bio PEGylated Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Iris Biotech Laysan Bio PEGylated Drugs Production Growth Rate (2014-2019) Table Iris Biotech Laysan Bio PEGylated Drugs Production Market Share (2014-2019) Figure Iris Biotech Laysan Bio PEGylated Drugs Revenue Market Share (2014-2019) Table Iris Biotech Laysan Bio PEGylated Drugs Main Business and Markets Served Figure Global PEGylated Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global PEGylated Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global PEGylated Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India PEGylated Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India PEGylated Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of PEGylated Drugs by Type (2019-2025) Table Global Consumption (K Units) of PEGylated Drugs by Application (2019-2025) Table PEGylated Drugs Distributors List Table PEGylated Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Thermo Fisher Scientific Merck Johnson & Johnson Creative PEGworks NOF Quanta BioDesign Celares Biomatrik Iris Biotech Laysan Bio